Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial

Faizah Alotaibi; Naif Khalaf Alharbi; Lindsey B. Rosen; Ayed Y. Asiri; Abdullah M. Assiri; Hanan H. Balkhy; Majed Al Jeraisy; Yasser Mandourah; Sameera AlJohani; Shmeylan Al Harbi; Hani A. Aziz Jokhdar; Ahmad M. Deeb; Ziad A. Memish; Jesna Jose; Sameeh Ghazal; Sarah Al Faraj; Ghaleb A. Al Mekhlafi; Nisreen Murad Sherbeeni; Fatehi Elnour Elzein; Badriah M. AlMutairi; Abdulaziz Al-Dawood; Mashan L. Abdullah; Tlili Barhoumi; Mohammed W. Alenazi; Abdulrahman Almasood; Steven M. Holland; Yaseen M. Arabi; the Saudi Critical Care Trials Group

doi:10.1111/irv.13116

Back

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial

Journal article

Open access

Peer reviewed

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial

Faizah Alotaibi, Naif Khalaf Alharbi, Lindsey B. Rosen, Ayed Y. Asiri, Abdullah M. Assiri, Hanan H. Balkhy, Majed Al Jeraisy, Yasser Mandourah, Sameera AlJohani, Shmeylan Al Harbi, …

Influenza and other respiratory viruses, Vol.17(3), pp.e13116-n/a

03/2023

DOI: https://doi.org/10.1111/irv.13116

PMID: 36960162

Files and links (1)

url

https://doi.org/10.1111/irv.13116View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial
Creators - without role: Faizah Alotaibi - King Saud bin Abdulaziz University for Health Sciences
Naif Khalaf Alharbi - King Saud bin Abdulaziz University for Health Sciences
Lindsey B. Rosen - National Institute of Allergy and Infectious Diseases
Ayed Y. Asiri - Prince Mohammed bin Abdulaziz Hospital
Abdullah M. Assiri - Ministry of Health
Hanan H. Balkhy - World Health Organization
Majed Al Jeraisy - King Saud bin Abdulaziz University for Health Sciences
Yasser Mandourah - Riyadh Armed Forces Hospital
Sameera AlJohani - King Saud bin Abdulaziz University for Health Sciences
Shmeylan Al Harbi - King Saud bin Abdulaziz University for Health Sciences
Hani A. Aziz Jokhdar - Ministry of Health
Ahmad M. Deeb - King Saud bin Abdulaziz University for Health Sciences
Ziad A. Memish - Prince Mohammed bin Abdulaziz Hospital
Jesna Jose - King Abdullah International Medical Research Center
Sameeh Ghazal - Prince Mohammed bin Abdulaziz Hospital
Sarah Al Faraj - Riyadh Armed Forces Hospital
Ghaleb A. Al Mekhlafi - Riyadh Armed Forces Hospital
Nisreen Murad Sherbeeni - Riyadh Armed Forces Hospital
Fatehi Elnour Elzein - Riyadh Armed Forces Hospital
Badriah M. AlMutairi - King Saud bin Abdulaziz University for Health Sciences
Abdulaziz Al-Dawood - King Saud bin Abdulaziz University for Health Sciences
Mashan L. Abdullah - King Saud bin Abdulaziz University for Health Sciences
Tlili Barhoumi - King Saud bin Abdulaziz University for Health Sciences
Mohammed W. Alenazi - King Saud bin Abdulaziz University for Health Sciences
Abdulrahman Almasood - King Saud bin Abdulaziz University for Health Sciences
Steven M. Holland - National Institute of Allergy and Infectious Diseases
Yaseen M. Arabi - King Saud bin Abdulaziz University for Health Sciences
the Saudi Critical Care Trials Group
Publication Details: Influenza and other respiratory viruses, Vol.17(3), pp.e13116-n/a
Identifiers: 9913622708331
Academic Unit: Alfaisal University; King Abdulaziz University; King Saud University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article